Log In
Print
BCIQ
Print
Print this Print this
 

APS001F

  Manage Alerts
Collapse Summary General Information
Company Anaeropharma Science Inc.
DescriptionRecombinant anaerobic bacteria Bifidobacterium modified to express the cytosine deaminase (CD) gene
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Non-viral vector
Latest Stage of DevelopmentPhase I/II
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today